SynthesisBritish dental journal2019
A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism.
Synthesis in British dental journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of the Chewing Performance and Nutritional Status of the Patients Diagnosed With Bruxism After Botulinum Toxin Application: Follow-up Study
Preliminary Findings of the Efficacy of Botulinum Toxin in Temporomandibular Disorders: A Randomized Clinical Trial
Botulinum Toxin in the Management of Temporo-mandibular Related Myalgia: a Prospective Study
Who cites it
31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 96 citations in OpenAlex.
- Botulinum Toxin for Bruxism: An Overview.Toxins · 2025Pooled it
- Pooled it
- Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial.Scientific reports · 2024Trial
- Perception of patients with temporomandibular disorders of the effects of botulinum toxin application: a retrospective cross-sectional observational study.Clinical oral investigations · 2026Observational
- The efficacy, safety, and cost-effectiveness of TMJ balancing therapy for temporomandibular joint disorder: study protocol for a randomized controlled trial.BMC complementary medicine and therapies · 2026Article
- The Management of Myogenous Temporomandibular Disorders with Botulinum Toxin: A Narrative Review and Management Recommendations.Current pain and headache reports · 2026Review
- A Clinical Decision-Making Algorithm for Botulinum Toxin Use in Temporomandibular Disorders and Bruxism.Journal of clinical medicine · 2026Article
- OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group.Toxins · 2025Article
- Patient-Reported Outcome Measures After Botulinum Toxin for Temporomandibular-Related Myalgia: A Prospective Study.Journal of clinical medicine · 2025Article
- Botulinum toxin A injections and adverse effects to mimic muscle in TMD myofascial pain treatment: a case report.Journal of medical case reports · 2025Article
- Spin Bias in randomized controlled trials of botulinum toxin for bruxism management: a meta-epidemiologic study.BMC medical research methodology · 2025Article
- Review
- Article
- Impact of manual therapy on body posture-3-D analysis with rasterstereography - pilotstudy.Head & face medicine · 2024Article
- Review
- Botulinum toxin for bruxism treatment: a nationwide study among oral and maxillofacial surgeons in Germany.Clinical oral investigations · 2024Article
- Effects of different interventions on bruxism: an overview of systematic reviews.Sleep & breathing = Schlaf & Atmung · 2024Review
- Temporomandibular Disorders Management-What's New? A Scoping Review.Dentistry journal · 2024Article
- Dental patients' tinnitus profile: prevalence, types, and associated factors with oral and maxillofacial diseases.Acta odontologica Scandinavica · 2024Article
- Temporomandibular joint injection therapy.Journal of the Korean Association of Oral and Maxillofacial Surgeons · 2024Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction The medical and cosmetic use of botulinum toxin (BTX) is now widespread. With an increased number of clinicians adopting the use of BTX in the management of temporomandibular disorders (TMD) and/or bruxism, as either a standalone treatment or as an adjunct, affirmation is required in regards to whether it has a clinically justifiable position among the current spectrum of available treatment modalities.Objectives To establish the usefulness of BTX when treating patients with TMD and/or bruxism, and thereby determine whether there may be an appropriate purpose for the prescription of BTX in the management of these patients.Data sources and data selection A systematic review of the relevant literature was conducted. The literature search was carried out by applying key terms to appropriate data sources (Medline, Embase, Pubmed, Cochrane Central Register of Controlled Trials, and OpenSIGLE). The resultant papers were subjected to inclusion and exclusion criteria, which were then assessed for bias using a framework outlined in the Cochrane Handbook.Results A total of 11 trials met the inclusion criteria. The primary outcome measure was changes in pain experience in groups that had been treated with BTX, relative to an appropriate control group. Secondary outcomes included changes in the frequency of bruxism events, changes in maximum mouth opening, changes in occlusal force and changes in electromyography (EMG) readings of muscles of mastication.Conclusion The evidence to support the use of BTX in the management of TMD and/or bruxism is not entirely unequivocal. A number of studies that have met the inclusion criteria have shown promising results and thereby justify further investigation. Given the current evidence, BTX should certainly be considered but due to financial implications and possible side effects, it seems appropriate that conservative options, such as self-management with explanation and physical therapies, should be exhausted first.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.